Atossa Genetics Inc news

   Watch this stock
Showing stories 1 - 10 of about 25   

Articles published

ATOS 1.09 -0.10 (-8.40%)
price chart
Atossa Genetics Inc. Wins Dismissal of Securities Class Action Litigation
SEATTLE, WA, Oct 31, 2014 (Marketwired via COMTEX) -- Atossa Genetics Inc. ATOS, -8.40% today announced that the U.S. District Court for the Western District of Washington has granted the defendants' motion to dismiss the amended complaint in the ...
Atossa Beats Claims It Duped Investors In $4M Offering  Law360 (subscription)
Related articles »  
Atossa Genetics gets some good news in Europe
"This approval marks an essential pivot point for Atossa as we pursue commercialization of the ForeCyte Breast Aspirator into various European markets," said Steven Quay, chairman, CEO and president of Atossa, in a statement. Shares in Atossa Genetics ...
Atossa Genetics Receives CE Mark for the ForeCYTE Breast Aspirator Device  CNNMoney
Related articles »  
Atossa Genetics to Present at the 13th Annual BIO Investor Forum October 8, 2014
Atossa Genetics, Inc. (NASDAQ: ATOS) today announced that Kyle Guse, CFO and General Counsel, will be a featured presenter at the 13th Annual BIO Investor Forum on October 8, 2014 a 3:00 PM at the Palace Hotel in San Francisco, CA, in the Sea Cliff ...
Related articles »  
The Latest On Image Sensing Systems (ISNS), Atossa Genetics (ATOS), Super ...
On the average, Wall Street expects Image Sensing Systems to earn a loss of $0.13 per share on revenue of $7.21 million for the upcoming report.
Related articles »  
Atossa Genetics Inc. Provides Regulatory and Commercial Update on Its ...
SEATTLE, WA -- (Marketwired) -- 09/23/14 -- Atossa Genetics Inc. (NASDAQ: ATOS) today announced that the U.S. Food and Drug Administration has issued a determination that the ForeCYTE Breast Aspirator is "not substantially equivalent" to its predicate ...
Related articles »  
Investors Alert: Atossa Genetics Inc (NASDAQ:ATOS), Intel Corporation ...
Lakeway, NY - (MARKET NEWS CALL) - 9/24/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Related articles »  
Notable Movers-MolycorpInc (NYSE:MCP), Atossa Genetics Inc (NASDAQ:ATOS ...
New York, NY- September 25, 2014 - (Techsonian) - SMS Penny Picks moves markets� Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of ...
Related articles »  
Investors Alert: CSX Corp. (NYSE:CSX), Bitauto Holdings Limited (NYSE:BITA ...
On last trading day Atossa Genetics, Inc. (NASDAQ:ATOS) moved up 7.32% to close at $0.88. Its volatility for the week is 12.69% while volatility for the month is 11.68%.
Hot Alert: United Continental Holdings, Inc. (NYSE:UAL), CEMEX, S.A.B. de C.V. ...
Atossa Genetics, Inc. (NASDAQ:ATOS) on Sept. 23 announced that the U.S. Food and Drug Administration has issued a determination that the ForeCYTE Breast Aspirator is �not substantially equivalent� to its predicate device.
Related articles »  
5 Stocks Under Wall Street's Radar : LinkedIn Corporation (NYSE:LNKD), J. C. ...
Atossa Genetics, Inc. (NASDAQ: ATOS) announced that Kyle Guse, CFO and General Counsel, will be a featured presenter at the 13th Annual BIO Investor Forum on October 8, 2014 a 3:00 PM at the Palace Hotel in San Francisco, CA, in the Sea Cliff Room.
Related articles »